Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study ...
Having parents with a history of smoking is associated with a significantly increased risk of developing pediatric MS, a ...
For years, columnist Ben Hofmeister avoided talking about his invisible scars caused by the silent challenges of life with MS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results